Early day motion tabled by primary sponsor Stephen Doughty (Labour and Co-operative Party), on Monday, 8 April 2019, in the House of Commons. It is signed by 36 members in total.

---

FAIR PRICING FOR MEDICINES

That this House notes with deep concern that the issue of excessively high medicine prices and systemic lack of transparency in the Research & Development (R&D) system is a global crisis; further notes that the second Fair Pricing Forum will take place in April 2019 presenting a critical opportunity for stakeholders to discuss how to respond to arbitrary priced medicines and define what is a fair price for medicines; acknowledges that different people will have different understandings of what is fair price; believes that a definition of fairness must prioritise access to medicines and transparency of R&D outlays and price-setting; and calls on the UK Government and other World Health Organisation member states to support Italy’s draft resolution entitled, Improving the transparency of markets for drugs, vaccines and other health-related technologies that will be discussed at the 72nd World Health Assembly.

---

Secondary information

Type

Early day motion

Reference

2272 

Session

2017-19

Other sponsors

Jim Cunningham

Paul Farrelly

Mike Penning

Jim Shannon

Matt Western

Subjects

Medical treatments Prices

Link

View this Early day motion on edm.parliament.uk